A rapid Iiquid-chromatographic method is described for simultaneously determining prednisone, prednisolone, and cortisol in plasma. Before chromato9raphy, samples containing an internal standard (methylprednisolone) were extracted with use of Chem Elut (Analytichem) columns. After elution of the glucocorticosteroids, the eluates were dried and reconstituted in a mobile phase of tetrahydrofuran/water (25/75 by vol). Samples were injected onto a reversed-phase C18 column, and analysis time was 15.5 mm. Measures of analytical performance were all acceptable, and the method was used to assess noncompliance in pediatric renal-transplant recipients who were receiving prednisone and cyclosporine. Of the 37 pediatric patients tested, five (13.5%) were identified as noncompliant. lacked reproducibility in our laboratory. We also tried various pretreatments of plasma samples, as described by several authors (3, 4, (6) (7) (8) , and found them generally unsuitable. We achieved success by using an improved sample-extraction technique with a solid-phase approach (5) and established a method for measuring plasma glucocorticosteorid concentrations for which the results could be reported to our renal-transplant group on the morning that the patient was at the clinic. These results helped identify those pediatric patients who did not comply with immunosuppressive therapy.
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Materials and Methods

Materials
Instrumentation.
The liquid-chromatographic system included a Model U6K injector, a Model 6000A pump (both from Waters Chromatography Division of Millipore Corp., Milford, MA 01757), and a Shimadzu SPD-6A ultraviolet detector (Cole Scientific, Inc., Calabasas, CA 91302). The analytical column was an Axxiom octadecylsilyl-C18 reversed-phase column (4.6 x 150 mm) of 5-.iL particle size (Cole Scientific). We used 3-mL Chem ElutTh columns (Analytichem International, Inc., Harbor City, CA 90710) to pretreat plasma samples. (1 gIL), and cortisol (1 g/L), and of the internal standard, methylprednisolone (1 g/L), were prepared in methanol and stored at 4#{176}C for as long as three months.
Reagents. Methylene chloride (Fisher Scientific
,
Working standards
were prepared by adding steroids to drug-free plasma from blood-bank donors. Before adding the steroids, we chromatographed aliquots of the blood-bank plasma to ensure that it did not contain the steroids of interest. For prednisone, the working standards had concentrations of 10, 20, 50, 100, 200, 400, and 500 ug/L, and for prednisolone, 10, 20, 50, 100, 200, 400, and 500 p.gfL. For cortisol, working standards with concentrations of 10, 20, 50, 100,200, 300, and 400 ag/L were prepared in a 0.1 mol/L phosphate buffer containing, per liter, 10 g of bovine serum albumin with 1 g of sodium azide as preservative.
For intra-and interassay precision studies, we prepared prednisone and prednisolone at concentrations of 50, 150, and 400 gIL in drug-free plasma and stored For analytical recovery studies, we used steroids added to the same matrices as were used in the reproducibility studies. Briefly, 10, 75, 150, and 300 /.Lg/Lof both prednisone and prednisolone and 10, 75, 150, 400, and 500 pg/L of cortisol were added to matrices, extracted similarly to plasma samples, and compared with nonextracted standards.
Various medications administered to pediatric transplant patients were obtained from the hospital pharmacy. The drugs were added to drug-free plasma and assayed by the technique to determine whether they interfered with the assay.
Mobile phase. The mobile phase (tetrahydrofuran:water, 25:75 by vol) was prepared in 2-L volumes, filtered, and degassed before use.
Patients and Sample Treatment
Plasma samples (n = 68) were obtained from 37 pediatric patients attending the renal-transplant by liquid chromatography for the parent drug (CsA). Prednisone and CsA were usually taken at home by the patients daily between 0700 and 0900 h; however, on the day they came to the clinic they were requested not to take these drugs. Blood samples were drawn to obtain trough concentrations for steroids and CsA, so that the clinician could make dosage adjustments if necessary.
Before liquid chromatography, plasma samples for prednisone, prednisolone, and cortisol were treated as follows: Briefly, to 1.0 mL of plasma ( 
liquid Chromatography
The flow rate of the mobile phase was 1.2 mL/min at ambient temperature, detection was at 240 urn, the attenuation was at 0.005 A full-scale, and the chart speed was 0.5 cm/mn. We injected 20 pL of the sample supernate, and quantified the steroids in the sample by comparing the results with a standard curve based on the ratios of the peak heights of prednisone, prodnisolone, and cortisol to the peak height of the internal standard. Table 1 , and intra-and interassay precision is given in Table 2 .
Results
Interference studies were conducted with other ste- pediatric renal-transplant recipients successfully identified noncompliance in five of 37 patients (13.5%). Table  4 gives three examples of typical compliance with medication, illustrating that CsA and metabolites, as mea- roids and several medications commonly given to pediatric patients after transplantation. did not interfere with the analysis for the glucocorticosteroids (Table 3) .
Using this method to study plasma samples from
The method described in this report is a simple, precise, and specific method for simultaneously measuring prednisone, prednisolone, and cortisol in plasma of renal-transplant recipients who are taking CsA and prednisone.
Further, because of the rapidity of analysis, one can provide a glucocorticosteroid profile the same day that patients are attending the clinic. Usually, standards and controls are analyzed early in the morn- The assay is technically easy to perform and offers many advantages over those previously described (2) (3) (4) (5) (6) (7) (8) .
Most prednisone and corticosteroid procedures use normal-phase chromatography, which includes a polar material such as silica with a nonpolar solvent system.
These approaches have led to poor steroid separation. In earlier reversed-phase chromatography studies, prednisone and prednisolone co-eluted (6), and hydrocortisone and prednisolone
were not well resolved (9). With the method described here, prednisone, prednisolone, and cortisol are clearly resolved, the analysis is rapid, and other steroids and drugs commonly prescribed to renaltransplant patients do not interfere.
